Thử nghiệm ngẫu nhiên so sánh liệu pháp hormon thay thế liều thấp và HRT cộng với 1α-OH-vitamin D3 (alfacalcidol) trong điều trị tình trạng mất xương sau mãn kinh

WH Utian D Shoupe G Bachmann JV Pinkerton JH Pickar (2001) ArticleTitleRelief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate Fertil Steril 75 1065–1079 Occurrence Handle11384629 Occurrence Handle10.1016/S0015-0282(01)01791-5 Occurrence Handle1:STN:280:DC%2BD3MzhtFynsA%3D%3D JH Pickar I Yeh JE Wheeler MF Cunnane L Speroff (2001) ArticleTitleEndometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate Fertil Steril 76 25–31 Occurrence Handle11438315 Occurrence Handle10.1016/S0015-0282(01)01828-3 Occurrence Handle1:STN:280:DC%2BD3MzosVKjsw%3D%3D RA Lobo T Bush BR Carr JH Pickar (2001) ArticleTitleEffects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism Fertil Steril 76 13–24 Occurrence Handle11438314 Occurrence Handle10.1016/S0015-0282(01)01829-5 Occurrence Handle1:STN:280:DC%2BD3MzosVGrsA%3D%3D M Gambacciani P Monteleone AR Genazzani (2002) ArticleTitleLow-dose hormone replacement therapy: effects on bone Climacteric 5 135–139 Occurrence Handle12051108 Occurrence Handle1:CAS:528:DC%2BD38XltFSnt74%3D H Mizunuma H Okano M Soda I Kagami S Miyamoto T Tokizawa S Honjo Y Ibuki (1997) ArticleTitlePrevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: a 2-year prospective study Maturitas 27 69–76 Occurrence Handle9158080 Occurrence Handle10.1016/S0378-5122(97)01110-9 Occurrence Handle1:CAS:528:DyaK2sXjs1Cksbk%3D M Gambacciani M Ciaponi B Cappagli P Monteleone C Benussi G Bevilacqua AR Genazzani (2003) ArticleTitlePostmenopausal femur bone loss: effects of a low dose hormone replacement therapy Maturitas 45 175–183 Occurrence Handle12818462 Occurrence Handle10.1016/S0378-5122(03)00141-5 Occurrence Handle1:CAS:528:DC%2BD3sXks1Wls7o%3D R Lindsay JC Gallagher M Kleerekoper JH Pickar (2002) ArticleTitleEffect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women JAMA 287 2668–2676 Occurrence Handle12020302 Occurrence Handle10.1001/jama.287.20.2668 Occurrence Handle1:CAS:528:DC%2BD38XjvVygtbg%3D M Gambacciani M Ciaponi B Cappagli AR Genazzani (2001) ArticleTitleEffects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women Am J Obstet Gynecol 185 1180–1185 Occurrence Handle11717654 Occurrence Handle10.1067/mob.2001.117669 Occurrence Handle1:CAS:528:DC%2BD38XhslWrtw%3D%3D JE Rossouw GL Anderson RL Prentice AZ LaCroix C Kooperberg ML Stefanick RD Jackson SA Beresford BV Howard KC Johnson JM Kotchen J Ockene InstitutionalAuthorNameGroup for the Women's Health Initiative Investigators (2002) ArticleTitleRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321–333 Occurrence Handle12117397 Occurrence Handle1:CAS:528:DC%2BD38Xltlegs7k%3D V Beral InstitutionalAuthorNameMillion Women Study Collaborators (2003) ArticleTitleBreast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 419–427 Occurrence Handle12927427 Occurrence Handle10.1016/S0140-6736(03)14596-5 Occurrence Handle1:CAS:528:DC%2BD3sXmt1ajsrw%3D I Gorai O Chaki Y Taguchi M Nakayama H Osada N Suzuki N Katagiri Y Misu H Minaguchi (1999) ArticleTitleEarly postmenopausal bone loss is prevented by estrogen and partially by 1α-OH-vitamin D3: therapeutic effects of estrogen and/or 1α-OH-vitamin D3 Calcif Tissue Int 65 16–22 Occurrence Handle10369728 Occurrence Handle10.1007/s002239900651 Occurrence Handle1:CAS:528:DyaK1MXktlerur8%3D JC Gallagher SE Fowler JR Detter SS Sherman (2001) ArticleTitleCombination treatment with estrogen and calcitriol in the prevention of age-related bone loss J Clin Endocrinol Metab 86 3618–3628 Occurrence Handle11502787 Occurrence Handle1:CAS:528:DC%2BD3MXlvFekt7s%3D JC Gallagher PB Rapuri G Haynatzki JR Detter (2002) ArticleTitleEffect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers J Clin Endocrinol Metab 87 4914–4923 Occurrence Handle12414850 Occurrence Handle10.1210/jc.2002-020727 Occurrence Handle1:CAS:528:DC%2BD38Xos1ynsL4%3D B Ettinger HK Genant CE Cann (1987) ArticleTitlePostmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium Ann Intern Med 106 40–45 Occurrence Handle3789576 Occurrence Handle1:STN:280:BiiD2svkslI%3D AH MacLennan A MacLennan S Wenzel HM Chambers K Eckert (1993) ArticleTitleContinuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial Med J Aust 159 102–106 Occurrence Handle8336583 Occurrence Handle1:STN:280:ByyA3s%2FgvVM%3D M Shiraki K Kushida M Fukunaga H Kishimoto M Taga T Nakamura K Kaneda H Minaguchi T Inoue H Morii A Tomita K Yamamoto Y Nagata M Nakashima H Orimo (1999) ArticleTitleA double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis: the Alendronate Phase III Osteoporosis Treatment Research Group Osteoporos Int 10 183–192 Occurrence Handle10525709 Occurrence Handle10.1007/s001980050214 Occurrence Handle1:CAS:528:DyaK1MXnsVKhtLY%3D RR Recker KM Davies RM Dowd RP Heaney (1999) ArticleTitleThe effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women: a randomized, controlled trial Ann Intern Med 130 897–904 Occurrence Handle10375338 Occurrence Handle1:CAS:528:DyaK1MXjsleltLs%3D M Komulainen H Kroger MT Tuppurainen AM Heikkinen E Alhava R Honkanen J Jurvelin S Saarikoski (1999) ArticleTitlePrevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial J Clin Endocrinol Metab 84 546–552 Occurrence Handle10022414 Occurrence Handle10.1210/jc.84.2.546 Occurrence Handle1:CAS:528:DyaK1MXhtVCitLw%3D A Cranney G Wells A Willan L Griffith N Zytaruk V Robinson D Black J Adachi B Shea P Tugwell G Guyatt InstitutionalAuthorNameOsteoporosis Methodology Group and The Osteoporosis Research Advisory Group (2002) ArticleTitleMeta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women Endocr Rev 23 508–516 Occurrence Handle12202465 Occurrence Handle1:CAS:528:DC%2BD38Xnt1Wiur8%3D DM Black SL Greenspan KE Ensrud L Palermo JA McGowan TF Lang P Garnero ML Bouxsein JP Bilezikian CJ Rosen InstitutionalAuthorNamePaTH Study Investigators (2003) ArticleTitleThe effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis N Engl J Med 349 1207–1215 Occurrence Handle14500804 Occurrence Handle10.1056/NEJMoa031975 Occurrence Handle1:CAS:528:DC%2BD3sXns1Kmsrw%3D P Lips (2001) ArticleTitleVitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications Endocr Rev 22 477–501 Occurrence Handle11493580 Occurrence Handle10.1210/er.22.4.477 Occurrence Handle1:CAS:528:DC%2BD3MXms1aksL0%3D M Shiraki K Kushida K Yamazaki T Nagai T Inoue H Orimo (1996) ArticleTitleEffects of 2 years' treatment of osteoporosis with 1 alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study Endocr J 43 211–220 Occurrence Handle1:CAS:528:DyaK2sXhvFersLg%3D H Mizunuma H Okano M Soda S Tokizawa I Kagami S Miyamoto S Honjo Y Ibuki (1996) ArticleTitleCalcium supplements increase bone mineral density in women with low serum calcium levels during long-term estrogen therapy Endocr J 43 411–415 Occurrence Handle8930529 Occurrence Handle1:CAS:528:DyaK2sXitVyht7w%3D C Li G Samsioe C Borgfeldt PO Bendahl K Wilawan A Aberg (2003) ArticleTitleLow-dose hormone therapy and carbohydrate metabolism Fertil Steril 79 550–555 Occurrence Handle12620438 Occurrence Handle10.1016/S0015-0282(02)04762-3 A Goudev D Georgiev N Koycheva N Manasiev S Kyurkchiev (2002) ArticleTitleEffects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women Maturitas 43 49–53 Occurrence Handle12270582 Occurrence Handle10.1016/S0378-5122(02)00182-2 Occurrence Handle1:CAS:528:DC%2BD38Xnt1WqsLg%3D